132 related articles for article (PubMed ID: 11930117)
1. Mutations in exon 3 of the beta-catenin gene are rare in melanoma cell lines.
Pollock PM; Hayward N
Melanoma Res; 2002 Apr; 12(2):183-6. PubMed ID: 11930117
[TBL] [Abstract][Full Text] [Related]
2. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC.
Reifenberger J; Knobbe CB; Wolter M; Blaschke B; Schulte KW; Pietsch T; Ruzicka T; Reifenberger G
Int J Cancer; 2002 Aug; 100(5):549-56. PubMed ID: 12124804
[TBL] [Abstract][Full Text] [Related]
5. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
Rimm DL; Caca K; Hu G; Harrison FB; Fearon ER
Am J Pathol; 1999 Feb; 154(2):325-9. PubMed ID: 10027390
[TBL] [Abstract][Full Text] [Related]
6. Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis.
Murata M; Iwao K; Miyoshi Y; Nagasawa Y; Yabu M; Himeno S; Imanishi K; Ohsawa M; Wada H; Tominaga S; Shimano T; Kobayashi T; Nakamura Y
Cancer Lett; 2000 Oct; 159(1):73-8. PubMed ID: 10974408
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas.
Ueda M; Gemmill RM; West J; Winn R; Sugita M; Tanaka N; Ueki M; Drabkin HA
Br J Cancer; 2001 Jul; 85(1):64-8. PubMed ID: 11437403
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
9. Low frequency of beta-catenin gene mutations in pilomatricoma.
Ha SJ; Kim JS; Seo EJ; Lee KH; Lee HJ; Kim JW
Acta Derm Venereol; 2002; 82(6):428-31. PubMed ID: 12575848
[TBL] [Abstract][Full Text] [Related]
10. Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas.
Bellei B; Pacchiarotti A; Perez M; Faraggiana T
Mod Pathol; 2004 Oct; 17(10):1275-81. PubMed ID: 15195109
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
12. Analysis of beta-catenin gene mutations in pancreatic tumors.
Gerdes B; Ramaswamy A; Simon B; Pietsch T; Bastian D; Kersting M; Moll R; Bartsch D
Digestion; 1999; 60(6):544-8. PubMed ID: 10545724
[TBL] [Abstract][Full Text] [Related]
13. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
14. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
[TBL] [Abstract][Full Text] [Related]
15. beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; Contreras F; Palacios J
Br J Dermatol; 2001 Oct; 145(4):576-81. PubMed ID: 11703283
[TBL] [Abstract][Full Text] [Related]
16. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
17. Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability.
Kim IJ; Kang HC; Park JH; Shin Y; Ku JL; Lim SB; Park SY; Jung SY; Kim HK; Park JG
Clin Cancer Res; 2003 Aug; 9(8):2920-5. PubMed ID: 12912937
[TBL] [Abstract][Full Text] [Related]
18. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
19. Detection and analysis of beta-catenin mutations in prostate cancer.
Chesire DR; Ewing CM; Sauvageot J; Bova GS; Isaacs WB
Prostate; 2000 Dec; 45(4):323-34. PubMed ID: 11102958
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
